{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:51:07Z","timestamp":1777431067641,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,6]],"date-time":"2012-08-06T00:00:00Z","timestamp":1344211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1472-6882-12-116","type":"journal-article","created":{"date-parts":[[2012,8,6]],"date-time":"2012-08-06T12:14:50Z","timestamp":1344255290000},"source":"Crossref","is-referenced-by-count":30,"title":["Arctium lappa ameliorates endothelial dysfunction in rats fed with high fat\/cholesterol diets"],"prefix":"10.1186","volume":"12","author":[{"given":"Yun Jung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guk Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Gill","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Sub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,6]]},"reference":[{"key":"1140_CR1","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S0891-5849(02)01015-8","volume":"33","author":"KY Stokes","year":"2002","unstructured":"Stokes KY, Cooper D, Tailor A, Granger DN: Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med. 2002, 33: 1026-1036. 10.1016\/S0891-5849(02)01015-8.","journal-title":"Free Radic Biol Med"},{"key":"1140_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/sj.bjp.0705365","volume":"139","author":"M Madhani","year":"2003","unstructured":"Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ: Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol. 2003, 139: 1289-1296. 10.1038\/sj.bjp.0705365.","journal-title":"Br J Pharmacol"},{"key":"1140_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/sj.bjp.0704320","volume":"134","author":"XF Figueroa","year":"2001","unstructured":"Figueroa XF, Poblete MI, Boric MP, Mendiz\u00e1bal VE, Adler-Graschinsky E, Huidobro-Toro JP: Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation. Br J Pharmacol. 2001, 134: 957-968. 10.1038\/sj.bjp.0704320.","journal-title":"Br J Pharmacol"},{"key":"1140_CR4","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0008-6363(00)00169-3","volume":"48","author":"S Babaei","year":"2000","unstructured":"Babaei S, Picard P, Ravandi A, Monge JC, Lee TC, Cernacek P, Stewart DJ: Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation. Cardiovasc Res. 2000, 48: 158-167. 10.1016\/S0008-6363(00)00169-3.","journal-title":"Cardiovasc Res"},{"key":"1140_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/nm1195-1148","volume":"1","author":"M Grossman","year":"1995","unstructured":"Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ, Stein EA, Lupien PJ, Brewer HB, Raper SE: A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med. 1995, 1: 1148-1154. 10.1038\/nm1195-1148.","journal-title":"Nat Med"},{"key":"1140_CR6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-2275(20)32124-6","volume":"40","author":"MM Marsh","year":"1999","unstructured":"Marsh MM, Walker VR, Curtiss LK, Banka CL: Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res. 1999, 40: 893-900.","journal-title":"J Lipid Res"},{"key":"1140_CR7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1152\/ajpheart.00751.2004","volume":"288","author":"H Nishimatsu","year":"2005","unstructured":"Nishimatsu H, Suzuki E, Satonaka H, Takeda R, Omata M, Fujita T, Nagai R, Kitamura T, Hirata Y: Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats. Am J Physiol Heart Circ Physiol. 2005, 288: 1770-1776.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1140_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.nu.13.070193.002035","volume":"13","author":"DK Spady","year":"1993","unstructured":"Spady DK, Woollett LA, Dietschy JM: Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu Rev Nutr. 1993, 13: 355-381. 10.1146\/annurev.nu.13.070193.002035.","journal-title":"Annu Rev Nutr"},{"key":"1140_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.atherosclerosis.2011.10.009","volume":"220","author":"PT Skretteberg","year":"2012","unstructured":"Skretteberg PT, Grundvold I, Kjeldsen SE, Erikssen JE, Sandvik L, Liest\u00f8l K, Erikssen G, Pedersen TR, Bodegard J: HDL-cholesterol and prediction of coronary heart disease: Modified by physical fitness? A 28-year follow-up of apparently healthy men. Atherosclerosis. 2012, 220: 250-256. 10.1016\/j.atherosclerosis.2011.10.009.","journal-title":"Atherosclerosis"},{"key":"1140_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/heart.87.2.107","volume":"87","author":"F Andreotti","year":"2002","unstructured":"Andreotti F, Porto I, Crea F, Maseri A: Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart. 2002, 87: 107-112. 10.1136\/heart.87.2.107.","journal-title":"Heart"},{"key":"1140_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","volume":"170","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis. 2003, 170: 191-203. 10.1016\/S0021-9150(03)00097-2.","journal-title":"Atherosclerosis"},{"key":"1140_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1248\/cpb.55.150","volume":"55","author":"SY Park","year":"2007","unstructured":"Park SY, Hong SS, Han XH, Hwang JS, Lee D, Ro JS, Hwang BY: Lignans from Arctium lappa and their inhibition of LPS-induced nitric oxide production. Chem Pharm Bull (Japan). 2007, 55: 150-152. 10.1248\/cpb.55.150.","journal-title":"Chem Pharm Bull (Japan)"},{"key":"1140_CR13","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1021\/jf00058a007","volume":"43","author":"Y Maruta","year":"1995","unstructured":"Maruta Y, Kawabata J, Niki R: Antioxidative caffeoylquinic acid derivatives in the roots of burdock (Arctium lappa L.). J Agric Food Chem. 1995, 43: 2592-2595. 10.1021\/jf00058a007.","journal-title":"J Agric Food Chem"},{"key":"1140_CR14","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1248\/cpb.40.1196","volume":"40","author":"S Iwakami","year":"1992","unstructured":"Iwakami S, Wu JB, Fazuka Y, Sankawa W: Platelet activating factor (PAF) Antagonists contained in medicinal plants: Lignans and sesquiterpenes. Chem Pharm Biol. 1992, 40: 1196-1198. 10.1248\/cpb.40.1196.","journal-title":"Chem Pharm Biol"},{"key":"1140_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1099-1573(200002)14:1<1::AID-PTR580>3.0.CO;2-O","volume":"14","author":"C Tamayo","year":"2000","unstructured":"Tamayo C, Richardson MA, Diamond S, Skoda I: The chemistry and biological activity of herbs used in Flor-Essence herbal tonic and Essiac. Phytother Res. 2000, 14: 1-14. 10.1002\/(SICI)1099-1573(200002)14:1<1::AID-PTR580>3.0.CO;2-O.","journal-title":"Phytother Res"},{"key":"1140_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1248\/bpb.28.860","volume":"28","author":"DG Kang","year":"2005","unstructured":"Kang DG, Lee JK, Choi DH, Sohn EJ, Moon MK, Lee HS: Vascular relaxation by the methanol extract of Sorbus cortex via NO-cGMP pathway. Biol Pharm Bull. 2005, 28: 860-864. 10.1248\/bpb.28.860.","journal-title":"Biol Pharm Bull"},{"key":"1140_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1172\/JCI5971","volume":"104","author":"ZY Jiang","year":"1999","unstructured":"Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa\/fa) rats. J Clin Invest. 1999, 104: 447-457. 10.1172\/JCI5971.","journal-title":"J Clin Invest"},{"key":"1140_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3109\/08923973.2011.569889","volume":"34","author":"DH Choi","year":"2012","unstructured":"Choi DH, Lee YJ, Kim JS, Kang DG, Lee HS: Cynanchum wilfordii ameliorates hypertension and endothelial dysfunction in rats fed with high fat\/cholesterol diets. Immunopharmacol Immunotoxicol. 2012, 34: 4-11. 10.3109\/08923973.2011.569889.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1140_CR19","volume-title":"J Med Food","author":"DH Choi","year":"2011","unstructured":"Choi DH, Lee YJ, Oh HC, Cui YL, Kim JS, Kang DG, Lee HS: Improved Endothelial Dysfunction by Cynanchum wilfordii in Apolipoprotein E(\u2212\/\u2212) Mice Fed a High Fat\/Cholesterol Diet. J Med Food. 2011, 10.1089\/jmf.2010.1222."},{"key":"1140_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1172\/JCI11144","volume":"106","author":"NF Voelkel","year":"2000","unstructured":"Voelkel NF, Tuder RM: Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?. J Clin Invest. 2000, 106: 733-738. 10.1172\/JCI11144.","journal-title":"J Clin Invest"},{"key":"1140_CR21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2337\/db05-1147","volume":"56","author":"HG Zecchin","year":"2007","unstructured":"Zecchin HG, Priviero FB, Souza CT, Zecchin KG, Prada PO, Carvalheira JB, Velloso LA, Antunes E, Saad MJ: Defective insulin and acetylcholine induction of endothelial cell-nitric oxide synthase through insulin receptor substrate\/Akt signaling pathway in aorta of obese rats. Diabetes. 2007, 56: 1014-1024. 10.2337\/db05-1147.","journal-title":"Diabetes"},{"key":"1140_CR22","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1152\/ajpheart.00612.2006","volume":"292","author":"AH Siddiqui","year":"2007","unstructured":"Siddiqui AH, Hussain T: Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats. Am J Physiol Heart Circ Physiol. 2007, 292: 1722-1727.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1140_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/01.HYP.27.1.25","volume":"27","author":"H Takase","year":"1996","unstructured":"Takase H, Moreau P, K\u00fcng CF, Nava E, L\u00fcscher TF: Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Hypertension. 1996, 27: 25-31. 10.1161\/01.HYP.27.1.25.","journal-title":"Hypertension"},{"key":"1140_CR24","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1161\/CIRCRESAHA.108.171264","volume":"102","author":"PJ Bernal","year":"2008","unstructured":"Bernal PJ, Leelavanichkul K, Bauer E, Cao R, Wilson A, Wasserloos KJ, Watkins SC, Pitt BR, St Croix CM: Nitric-oxide-mediated zinc release contributes to hypoxic regulation of pulmonary vascular tone. Circ Res. 2008, 102: 1575-1583. 10.1161\/CIRCRESAHA.108.171264.","journal-title":"Circ Res"},{"key":"1140_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/01.ATV.0000051404.84665.49","volume":"23","author":"M Gervais","year":"2003","unstructured":"Gervais M, Pons S, Nicoletti A, Cosson C, Giudicelli JF, Richer C: Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003, 23: 183-189. 10.1161\/01.ATV.0000051404.84665.49.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1140_CR26","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00125-003-1246-x","volume":"46","author":"JB Carvalheira","year":"2003","unstructured":"Carvalheira JB, Ribeiro EB, Ara\u00fajo EP, Guimar\u00e3es RB, Telles MM, Torsoni M, Gontijo JA, Velloso LA, Saad MJ: Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia. 2003, 46: 1629-1640. 10.1007\/s00125-003-1246-x.","journal-title":"Diabetologia"},{"key":"1140_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1042\/bj3100741","volume":"310","author":"MJ Saad","year":"1995","unstructured":"Saad MJ, Velloso LA, Carvalho CR: Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem J. 1995, 310: 741-744.","journal-title":"Biochem J"},{"key":"1140_CR28","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1161\/01.ATV.17.9.1707","volume":"17","author":"SC Whitman","year":"1997","unstructured":"Whitman SC, Miller DB, Wolfe BM, Hegele RA, Huff MW: Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation. Arterioscler Thromb Vasc Biol. 1997, 17: 1707-1715. 10.1161\/01.ATV.17.9.1707.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1140_CR29","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1161\/01.CIR.103.17.2213","volume":"103","author":"AM Gotto Jr","year":"2001","unstructured":"Gotto AM: Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. Circulation. 2001, 103: 2213-2218. 10.1161\/01.CIR.103.17.2213.","journal-title":"Circulation"},{"key":"1140_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.amjcard.2009.02.061","volume":"104","author":"EA Stein","year":"2009","unstructured":"Stein EA, Stroes ES, Steiner G, Buckley BM, Capponi AM, Burgess T, Niesor EJ, Kallend D, Kastelein JJ: Safety and tolerability of dalcetrapib. Am J Cardiol. 2009, 104: 82-91. 10.1016\/j.amjcard.2009.02.061.","journal-title":"Am J Cardiol"},{"key":"1140_CR31","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(07)61813-3","volume":"370","author":"R Krishna","year":"2007","unstructured":"Krishna R, Anderson MS, Bergman AJ, Jin B, Fallon M, Cote J, Rosko K, Chavez-Eng C, Lutz R, Bloomfield DM: Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies. Lancet. 2007, 370: 1907-1914. 10.1016\/S0140-6736(07)61813-3.","journal-title":"Lancet"},{"key":"1140_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ahj.2008.09.022","volume":"157","author":"D Bloomfield","year":"2009","unstructured":"Bloomfield D, Carlson GL, Sapre A, Tribble D, McKenney JM, Littlejohn TW, Sisk CM, Mitchel Y, Pasternak RC: Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients. Am Heart J. 2009, 157: 352-360. 10.1016\/j.ahj.2008.09.022.","journal-title":"Am Heart J"},{"key":"1140_CR33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1161\/01.HYP.0000037969.41360.CC","volume":"40","author":"QN Diep","year":"2002","unstructured":"Diep QN, Amiri F, Touyz RM, Cohn JS, Endemann D, Neves MF, Schiffrin EL: PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension. 2002, 40: 866-871. 10.1161\/01.HYP.0000037969.41360.CC.","journal-title":"Hypertension"},{"key":"1140_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11906-004-0081-x","volume":"6","author":"DH Endemann","year":"2004","unstructured":"Endemann DH, Schiffrin EL: Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep. 2004, 6: 85-89. 10.1007\/s11906-004-0081-x.","journal-title":"Curr Hypertens Rep"},{"key":"1140_CR35","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/01.CIR.101.13.1500","volume":"101","author":"H Vink","year":"2000","unstructured":"Vink H, Constantinescu AA, Spaan JA: Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation. 2000, 101: 1500-1502. 10.1161\/01.CIR.101.13.1500.","journal-title":"Circulation"},{"key":"1140_CR36","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1172\/JCI114596","volume":"85","author":"ML Entman","year":"1990","unstructured":"Entman ML, Youker K, Shappell SB, Siegel C, Rothlein R, Dreyer WJ, Schmalstieg FC, Smith CW: Neutrophil adherence to isolated adult canine myocytes. Evidence for a CD18-dependent mechanism. J Clin Invest. 1990, 85: 1497-1506. 10.1172\/JCI114596.","journal-title":"J Clin Invest"},{"key":"1140_CR37","first-page":"160","volume":"1","author":"R Scalia","year":"1997","unstructured":"Scalia R, Salomon MG, Lefer AM: Characterization of thrombin-induced leukocyte endothelial cell interaction in the rat mesenteric microvasculature. Cardiovasc Pathobiol. 1997, 1: 160-166.","journal-title":"Cardiovasc Pathobiol"},{"key":"1140_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cyto.2004.04.006","volume":"29","author":"T Sasakawa","year":"2005","unstructured":"Sasakawa T, Sasakawa Y, Masunaga T, Fujitsu T, Hirayama Y, Ohkubo Y, Mutoh S: FK506 suppresses E-selectin, ICAM-1 and VCAM-1 expression on vascular endothelial cells by inhibiting tumor necrosis factor alpha secretion from peripheral blood mononuclear cells. Cytokine. 2005, 29: 67-71. 10.1016\/j.cyto.2004.04.006.","journal-title":"Cytokine"},{"key":"1140_CR39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","volume":"90","author":"ZS Galis","year":"2002","unstructured":"Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002, 90: 251-262.","journal-title":"Circ Res"},{"key":"1140_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00048.2003","volume":"85","author":"AC Newby","year":"2005","unstructured":"Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev. 2005, 85: 1-31. 10.1152\/physrev.00048.2003.","journal-title":"Physiol Rev"},{"key":"1140_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.arcmed.2009.07.006","volume":"40","author":"H Guo","year":"2009","unstructured":"Guo H, Shi Y, Liu L, Sun A, Xu F, Chi J: Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice. Arch Med Res. 2009, 40: 345-351. 10.1016\/j.arcmed.2009.07.006.","journal-title":"Arch Med Res"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-12-116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-12-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-12-116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T19:26:10Z","timestamp":1643138770000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-12-116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,6]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-12-116","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,6]]},"article-number":"116"}}